» Articles » PMID: 16307812

The Curative Role of Radiotherapy in Adenocarcinoma of the Prostate in Patients Under 55 Years of Age: a Rare Cancer Network Retrospective Study

Abstract

To determine whether radiation therapy could be an acceptable alternative to surgery in young patients with adenocarcinoma of the prostate, we analysed the outcome of 39 patients aged under 55 with organ confined tumours who received external radiation therapy in a curative intent. Our results suggest that similar local control in younger and older patients can be expected from either external beam radiotherapy or radical prostatectomy.

Citing Articles

Prostate cancer in young men: an important clinical entity.

Salinas C, Tsodikov A, Ishak-Howard M, Cooney K Nat Rev Urol. 2014; 11(6):317-23.

PMID: 24818853 PMC: 4191828. DOI: 10.1038/nrurol.2014.91.


The Rare Cancer Network: achievements from 1993 to 2012.

Patel A, Ozsahin M, Mirimanoff R, Bhatia S, Chang K, Miller R Rare Tumors. 2012; 4(3):e35.

PMID: 23087791 PMC: 3475942. DOI: 10.4081/rt.2012.e35.


Young age under 60 years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer.

Klayton T, Ruth K, Horwitz E, Uzzo R, Kutikov A, Chen D Radiother Oncol. 2011; 101(3):508-12.

PMID: 21889222 PMC: 3225561. DOI: 10.1016/j.radonc.2011.07.022.


Younger patients have poorer biochemical outcome after radical prostatectomy in high-risk prostate cancer.

Hong S, Nam J, Na W, Oh J, Yoon C, Jeong C Asian J Androl. 2011; 13(5):719-23.

PMID: 21706038 PMC: 3739588. DOI: 10.1038/aja.2011.39.


Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis.

Hayes J, Ollendorf D, Pearson S, Barry M, Kantoff P, Stewart S JAMA. 2010; 304(21):2373-80.

PMID: 21119084 PMC: 3055173. DOI: 10.1001/jama.2010.1720.